Genomic Landscape of Vinflunine Response in Metastatic Urothelial Cancer

Genomic Landscape of Vinflunine Response in Metastatic Urothelial Cancer

Background and Aims: Metastatic urothelial carcinoma (mUC) remains an incurable disease with limited treatment options after platinum-based chemotherapy and immune checkpoint blockade (ICB). Vinflunine has shown a modest increase in overall survival and remains a therapeutic option for chemo- and im...

Full description

Bibliographic Details
Main Authors: Alejandra Bernardini, Marta Dueñas, María Cruz Martín-Soberon, Carolina Rubio, Cristian Suarez-Cabrera, Raquel Ruiz-Palomares, Ester Munera-Maravilla, Sara Lázaro, Iris Lodewijk, Daniel Rueda, David Gómez-Sánchez, Teresa Alonso-Gordoa, Javier Puente, Álvaro Pinto, Pilar González-Peramato, Carlos Aguado, Mercedes Herrera, Flora López, Victor M. G. Martinez, Lucía Morales, Daniel Castellano, Jesús M. Paramio, Guillermo de Velasco
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Cancers
Subjects:
urothelial cancer
bladder
vinflunine
biomarkers
immune signatures
Online Access:https://www.mdpi.com/2072-6694/14/2/378

Internet

https://www.mdpi.com/2072-6694/14/2/378

Similar Items